Provision Holding to Present at the LD Micro Invitational
Dec 01, 2016 12:30 pm UTC| Business
LOS ANGELES, Dec. 01, 2016 -- Provision Holding, Inc. (OTCQB:PVHO), today announced that it will be presenting at the 9th annual LD Micro Main Event Invitational on December 7 at 9:00 a.m. PST. Curt Thornton, CEO of...
Cytokinetics Announces Start of GALACTIC-HF, a Phase 3 Clinical Trial of Omecamtiv Mecarbil
Dec 01, 2016 12:30 pm UTC| Business
Trial to be Conducted Under Special Protocol Assessment with the FDA Company Earns $26.7 Million Milestone Payment from Amgen SOUTH SAN FRANCISCO, Calif., Dec. 01, 2016 -- Cytokinetics, Inc. (Nasdaq:CYTK) today...
T-Mobile US, Inc. to Present at the UBS Global Media & Communications Conference in New York, NY
Dec 01, 2016 12:30 pm UTC| Business
BELLEVUE, Wash., Dec. 01, 2016 -- J. Braxton Carter, Executive Vice President Chief Financial Officer of T-Mobile US, Inc. (NASDAQ:TMUS) will present at 9:15 a.m. Eastern Standard Time on Monday, December 5, 2016 at...
L Brands Reports November 2016 Sales
Dec 01, 2016 12:15 pm UTC| Business
COLUMBUS, Ohio, Dec. 01, 2016 -- L Brands, Inc. (NYSE:LB) reported net sales of $1.246 billion for the four weeks ended Nov. 26, 2016, an increase of 7 percent, compared to net sales of $1.169 billion for the four weeks...
Informatica Named Member in New Amazon Web Services Public Sector Partner Program
Dec 01, 2016 12:01 pm UTC| Business
Booth #2619, AWS re:Invent, Las Vegas, Nevada, Dec. 1, 2016, Dec. 01, 2016 -- In an expansion of its long standing relationship with Amazon Web Services (AWS), Informatica®, the world’s No. 1 provider of data management...
Parker to Acquire Filtration Company CLARCOR in a Strategic Portfolio Transaction
Dec 01, 2016 12:00 pm UTC| Business
Strengthens Parker’s Filtration Business with Addition of Complementary Product Lines and MarketsExpected to Be Accretive to Cash Flow, EPS, and EBITDA Margins – Excluding One-time CostsSignificantly Increases Presence in...
Dec 01, 2016 12:00 pm UTC| Business
BERKELEY HEIGHTS, N.J., Dec. 01, 2016 -- Cyclacel Pharmaceuticals, Inc. (Nasdaq:CYCC) (Nasdaq:CYCCP) ("Cyclacel" or the "Company"), a biopharmaceutical company developing oral therapies that target the various phases of...